🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is for participants with glioblastoma. It can cause a t...
Status
Not Yet Recruiting
Location
University Hospitals Cleveland Medical Center
Start Date
2026-10
Trial ID
NCT07719127
Treatments Being Tested
Disulfiram (DSF) a safe, easily dosed, FDA-approved drug for the treatment ...
Status
Terminated
Location
University of California San Francisco, Fresno
Start Date
2021-08-18
Trial ID
NCT04485130
Treatments Being Tested
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by ...
Status
Not Yet Recruiting
Location
University of Oklahoma Health Campus
Start Date
2026-09
Trial ID
NCT07534332
Treatments Being Tested
The proposed phase I/II study of disulfiram (DSF) for patients with presume...
Status
Completed
Location
Washington University School of Medicine
Start Date
2016-06-15
Trial ID
NCT02715609
Treatments Being Tested
This study of DSF-Cu in combination with TMZ for recurrent GBM will evaluat...
Status
Completed
Location
Beaumont Hospital
Start Date
2017-03-09
Trial ID
NCT03034135
Treatments Being Tested
Melanoma remains a malignancy that is largely resistant to chemotherapy. Me...
Status
Completed
Location
Chao Family Comprehensive Cancer Center
Start Date
2002-01
Trial ID
NCT00256230
Treatments Being Tested
The purpose of this study is to test the safety of combining the disulfiram...
Status
Recruiting
Location
Cleveland Clinic, Case Comprehensive Cancer Center
Start Date
2023-03-09
Trial ID
NCT05210374
Treatments Being Tested
One of Disulfiram antitumor effects suggested in preclinical studies is MGM...
Status
Terminated
Location
Aurora Health Care, Aurora St. Luke's Medical Center
Start Date
2018-03-28
Trial ID
NCT03363659
Treatments Being Tested
This is an open-label Phase 2 Pilot study to evaluate Disulfiram + Copper G...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2019-10-17
Trial ID
NCT03714555
Treatments Being Tested